Wednesday, July 18, 2018
 
 
Company News: Page (1) of 1 - 07/10/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
BayMark Health Services Opens Opioid Addiction Treatment Center in Kentwood
BayMark Health Services announced today the opening of MedMark Treatment Centers Kentwood, its first opioid treatment program in Michigan.
(July 10, 2018)

KENTWOOD, Mich. and LEWISVILLE, Texas, July 10, 2018 /PRNewswire-PRWeb/ -- BayMark Health Services announced today the opening of MedMark Treatment Centers Kentwood, its first opioid treatment program in Michigan. The clinic is located at 5500 Division Avenue S, Suite A, Kentwood, MI. MedMark Treatment Centers Kentwood will provide safe, effective medication-assisted treatment (MAT) and counseling for those struggling with opioid use disorder.

"Across the country, people are suffering from the devastating disease of addiction. The growing opioid crisis has resulted in a two-fold increase in overdose deaths in Michigan since 2012," said David K. White, Ph.D., CEO of BayMark Health Services. "Our focus at BayMark is offering access to proven treatment modalities to as many patients in need as possible. We open programs in areas where treatment options for opioid addiction are limited and there is an identified need, and we found the Greater Grand Rapids area met these criteria."

MedMark programs are known across the country as providers of quality, evidence-based methadone and buprenorphine treatment centers. MedMark programs also provide addiction education, relapse prevention, lab testing, coordinated care for pregnancy and linkages to community resources to assist patients on their path to recovery. Our mission is to provide comprehensive medication-assisted treatment for opioid use disorder and other health care services to foster wellness, longevity and socially responsible behavior for the patients we serve.



Chief Operating Officer Frank Baumann noted, "We are pleased to bring our treatment model to Michigan for the first time. MedMark's medically-supervised treatment programs have provided the opportunity for meaningful recovery to thousands of Americans. Our physicians, nurses, counselors and support staff offer compassionate, respectful treatment of those struggling with opioid use disorder. We believe we can deliver a valuable service to those individuals and their families in the greater Grand Rapids area."

For more information on MedMark visit https://medmark.com/

About BayMark Health Services:

BayMark Health Services provides medication-assisted treatment to more than 46,000 patients in recovery from opioid use disorder. Our outpatient programs deliver medically supervised treatment, in a variety of modalities and settings, to meet the diverse needs of our patients who struggle with the use of prescription pain medication or other opiates. The BayMark continuum of patient-focused services includes highly structured opioid treatment programs utilizing methadone or buprenorphine and office-based buprenorphine programs, both of which incorporate counseling as part of an individualized treatment plan; as well as, ambulatory withdrawal management services with naltrexone therapy, residential treatment and recovery support services.

 

SOURCE BayMark Health Services

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:Disease,Aging,Pregnancy,Therapy,Surgery,Medication,Pregnancy,Business,Science,Management Services,Medical,Other,
Related Sites: DMN Newswire ,   itbusinessnet.com ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   IBN - IT Weekly Newsletter ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Implantable Medical Devices Market Predicted to be Worth US$ 49.8 Bn by 2024, Says TMR
  • Global Cosmetic Chemicals Industry
  • HMP's 8th Annual Amputation Prevention Symposium Expected to Draw 800 Clinicians to Chicago to Join the CLI Revolution
  • Progressive Care Inc. Announces Month-End Sales Figures Showing Increase in Year-Over-Year Prescriptions Filled in June 2018

    Cancer
  • Camurus Announces PDUFA Date for CAM2038 for the Treatment of Opioid use Disorder
  • Association of Community Cancer Centers and Advisory Board Launch 9th Annual Trends in Cancer Care Survey
  • Small Animal Imaging Market is Estimated to Grow at a Faster Pace With the Significant CAGR During the Forecast Period: Radiant Insights, Inc.
  • Presage Biosciences Closes Series D Financing with Takeda and Celgene, and Announces Appointment of Richard Klinghoffer, PhD as Chief Executive Officer
  • Presage Biosciences Closes Series D Financing with Takeda and Celgene, and Announces Appointment of Richard Klinghoffer, PhD as Chief Executive Officer
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines